Breo vs. Ventolin
See how Breo and Ventolin compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Breo is a once-daily maintenance inhaler that controls asthma and COPD over time, while Ventolin is a rescue inhaler used for sudden breathing problems.
Breo combines a steroid and long-acting bronchodilator and cannot treat an active asthma attack, which is exactly what Ventolin is designed to do.
Because they serve different purposes, many patients use both: Breo every day for control and Ventolin as needed for flare-ups.
Breo vs. Ventolin Drug Summary
Breo
Breo is a combination inhaled corticosteroid and long-acting beta-agonist (ICS/LABA) taken once daily to control asthma and COPD over time. It is delivered through a dry-powder Ellipta inhaler and is not meant for sudden symptoms. Breo is FDA-approved for asthma in patients 5 and older and for COPD maintenance.
Ventolin
Ventolin is a short-acting beta-agonist (SABA) bronchodilator used to relieve sudden asthma or COPD symptoms as they happen. It is inhaled through a metered-dose HFA inhaler and taken as needed rather than on a fixed schedule. Ventolin is FDA-approved for bronchospasm relief and for preventing exercise-induced symptoms in patients 4 and older.
Breo vs. Ventolin Side Effects
Breo
Ventolin
Breo vs. Ventolin Dosage
Breo
Ventolin
| STAGE | DOSE | WHEN |
| Starting dose | 50 mcg/25 mcg once daily | At the start |
| Maximum dose | 50 mcg/25 mcg once daily | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 2 inhalations pre-exercise | At the start |
| Maximum dose | 2 inhalations pre-exercise | Same as starting |
| Dose changes | None | Fixed dose |
Breo
| STAGE | DOSE | WHEN |
| Starting dose | 50 mcg/25 mcg once daily | At the start |
| Maximum dose | 50 mcg/25 mcg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Ventolin
| STAGE | DOSE | WHEN |
| Starting dose | 2 inhalations pre-exercise | At the start |
| Maximum dose | 2 inhalations pre-exercise | Same as starting |
| Dose changes | None | Fixed dose |
Breo vs. Ventolin Indications
Breo
Breo is approved as a daily maintenance treatment for asthma in patients 5 and older and for COPD, including chronic bronchitis and emphysema. It works by reducing airway inflammation and keeping airways open over 24 hours. It is not a substitute for a rescue inhaler during an attack.
Maintenance treatment of asthma (ages 5+)
Maintenance treatment of COPD, including chronic bronchitis and emphysema
Available in three dose strengths for different needs
Not approved for acute bronchospasm or exacerbations
Ventolin
Ventolin is approved to treat or prevent bronchospasm in patients 4 and older with reversible airway disease. It is also used shortly before exercise to prevent exercise-induced bronchospasm. It works within minutes to open airways during an asthma or COPD flare.
Treatment of acute bronchospasm (ages 4+)
Prevention of exercise-induced bronchospasm
Used as needed, not on a fixed daily schedule
Not approved for children under 4
Breo vs. Ventolin Pros and Cons
Breo
Breo treats the underlying inflammation behind asthma and COPD with one inhalation a day, which can simplify long-term management. Because it contains a LABA, it carries a boxed warning and must be paired with a steroid, which is already built into the combination. It costs more than a rescue inhaler like Ventolin, though a GSK savings program can lower the price for eligible patients.
Pros
Once-daily dosing simplifies long-term control
Treats underlying airway inflammation, not just symptoms
Approved for both asthma and COPD
As low as $0 to $35 per month for eligible patients under GSK's copay cap program
Cons
Boxed warning for increased asthma-related death risk with LABA use
Not for acute symptoms; cannot replace a rescue inhaler
Contraindicated in patients with severe milk protein allergy
Roughly $225 to $550 per month without insurance, before savings programs
Ventolin
Ventolin acts within minutes to relieve sudden bronchospasm, making it the standard rescue option for asthma and COPD flares. It does not address airway inflammation, so it is not meant for daily long-term control. It is inexpensive and widely available, especially as a generic.
Pros
Works within minutes to relieve acute symptoms
Roughly $28 to $45 per month without insurance, far less than Breo's list price
Can be used as needed rather than on a schedule
Effective for preventing exercise-induced bronchospasm
Cons
Does not treat underlying airway inflammation
Overuse can raise risk of serious cardiovascular effects
Frequent use often signals poor asthma or COPD control
Not intended for regular, everyday symptom management
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.